摘要:
A thermotropic poly(ester carbonate) containing diacyl moieties such as terephthalate and carbonate moieties as well as dihydroxy-derived moieties is useful for forming fibers or films. The dihydroxy-derived moieties are at least 40% derived from t-butylhydroquinone, with hydroquinone and methylhydroquinone being exemplary second components. The polymers can be prepared by melt, solution or interfacial polymerization, are liquid crystalline in the melt and have glass transition temperatures above 100.degree. C.
摘要:
Thermotropic poly(ester carbonates) such as the terephthalate/carbonate of a mixture of hydroquinose, resorcinol, tert-butylhydroquinone and methylhydroquinone. With a major proportion of the more readily available hydroquinone and resorcinol, thermotropic properties (liquid crystallinity in the melt) are observed.
摘要:
A thermotropic polyester carbonate containing aromatic diacyl moieties, aromatic dihydroxy moieties and carbonate moieties, wherein up to 50 mole percent of the aromatic dioxy moieties are replaced with aliphatic dihydroxy moiety, such as 2,2-dimethyl-1,3-propanediol.
摘要:
Biomedical devices are provided herein which are formed from a polymerization product of a mixture comprising (a) a copolymer which is the reaction product of one or more polymerizable polyhydric alcohols and one or more polymerizable fluorine-containing monomers; and (b) a biomedical device-forming comonomer.
摘要:
Polysiloxanes having vinyl or epoxy functionality. The polysiloxanes are used to form polymer-based materials having properties particularly suited for biomedical device applications. The polysiloxanes are of general formula I: wherein R is a C2-10 alkenyl, a C2-10 alkyl with an epoxy group or a C5-C7cycloalkyl with an epoxy group; R2, R3 and R4 are each independently selected from the group consisting of hydrogen, C1-4 alkyl, C1-4 fluoroalkyl, optionally substituted phenyl and optionally substituted benzyl; A is —OH or —NHR5, wherein R5 is hydrogen or a C1-3 alkyl; and B is —R1-A or —R6, wherein R1 is a linking group having an alkylene group with 2 to 8 carbon atoms wherein the alkylene group optionally includes ether, urethane or ureido linkages; and R6 is selected from the group consisting of C1-4 alkyl, optionally substituted phenyl or optionally substituted benzyl; and m and n are integers with an m:n ratio from 30:1 to 3:1.
摘要:
Packaging systems for storing ophthalmic devices such as contact lenses and to methods for packaging such ophthalmic devices with solutions to improve the comfort of the lenses during wear are disclosed. A packaging system includes an ophthalmic device stored in an aqueous packaging solution comprising a hydrophilic polymer having one or more non-ethylenically-unsaturated carboxylic acid terminal groups.
摘要:
A process for treating a silicone hydrogel biomedical device, especially an ophthalmic lens such as a contact lens, involves: immersing the silicone hydrogel biomedical device with a mixture of an organic solvent and a hydrophilic, polymeric material, for a sufficient time that the device is swollen in volume by at least 30%; and removing the organic solvent from the device while retaining at least a portion of the hydrophilic polymeric material therein.
摘要:
A drug delivery device for placement in the eye includes a drug core comprising a hydrophobic pharmaceutically active agent, and a holder that holds the drug core. The holder is made of a material impermeable to passage of the active agent and includes an opening for passage of the pharmaceutically agent therethrough to eye tissue. The device includes polyurethane-siloxane-containing copolymers crosslinked with hydrophilic monomers.
摘要:
A macromonomer comprises an α,β-conjugated terminal carboxylic group and a plurality of hydrophilic groups. Polymeric materials comprise such a macromonomer are used advantageously to provide a hydrophilic or lubricious (or both) coating on medical devices. Such polymeric materials can comprise units of other hydrophilic monomers.
摘要:
A process for producing silicone intraocular lenses (IOLs) capable of absorbing blue light. Intraocular lenses so produced block blue light from reaching the retina of an eye implanted with the IOL. By blocking blue light from reaching the retina, the IOL thereby prevents potential damage to the retina.